TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GG00BKTRRM22
Issuer Name
RTW BIOTECH OPPORTUNITIES LTD
UK or Non-UK Issuer
Non-UK
2. Reason for Notification
Other
Comments
As a result of RTW Biotech Opportunities Ltd.'s ("RTW") recent cancellation of 48,322,863 of its shares, Bluestem's interest in RTW has increased to 10.14%, which triggers the notification threshold.
3. Details of person subject to the notification obligation
Name
Bluestem Asset Management, LLC
City of registered office (if applicable)
Charlottesville
Country of registered office (if applicable)
United States
| Name | City of registered office | Country of registered office |
| Bluestem Partners, LP | Wilmington Delaware | USA |
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
24-May-2024
6. Date on which Issuer notified
24-May-2024
7. Total positions of person(s) subject to the notification obligation
| % of voting rights attached to shares (total of 8.A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer | |
| Resulting situation on the date on which threshold was crossed or reached | 10.140000 | 0.000000 | 10.140000 | 34,093,156 |
| Position of previous notification (if applicable) | 8.740000 | 0.000000 | 8.740000 | |
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
| Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
| GG00BKTRRM22 | 34,093,156 | | 10.140000 | |
| Sub Total 8.A | 34,093,156 | 10.140000% | ||
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
| Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
|
| | | | |
| Sub Total 8.B1 | | | | |
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
| Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |
|
| | | | | |
| Sub Total 8.B2 | | | | ||
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
| Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
| Michael D. Bills | Bluestem Asset Management LLC | 10.140000 | 0.000000 | 10.140000% |
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
Michael D. Bills has sole authority for Bluestem Asset Management, LLC, as its Managing Member. Bluestem Asset Management, LLC is the General Partner of the Shareholder, Bluestem Partners, LP, and is authorized to act for Bluestem Partners, LP on all matters.
The last notification was submitted to the FCA and the issuer on February 16, 2024. Bluestem's interest in RTW at that time was 8.74%.
12. Date of Completion
24-May-2024
13. Place Of Completion
Charlottesville, VA USA
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
